Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
Papers: 21 Aug 2015 - 28 Aug 2015
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
MS Research Roundup: May 27, 2014
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
MS Research Roundup: September 29, 2014
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.

Pages